1 Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection 10.000 for an international patent

 …in terms of product development

 3 Electrical Engineers            54.000

1 Doctor for advising                12.000

4 Laptop computers                    2.500

15 microphones                               600

Software licenses

SPSS                                                    100

LabView                                             300 

MATLAB                                             300


Signal Processing Laboratory     2000

Pneumonological Clinics          10.000

 … in terms of marketing



2 Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs 
  Year 1 Year 2 Year 3 Year 4 Year 5
Fixed costs 14.000        
Personnel 66.000 66.000 66.000 66.000 66.000
Other running costs 10.000        
Marketing costs 10.000 10.000 10.000 10.000 10.000
TOTAL EXPECTED COSTS 100.000 76.000 76.000 76.000 76.000
Price per Unit 1.000 1.000 1.000 1.000 1.000
Type of Unit  
Number of Units   50 200 300 500
TOTAL Expected Revenues   50.000 200.000 300.000 500.000
CASH FLOW REQUIRED (REVENUES-COSTS) -100.000 -26.000 124.000 224.000 424.000
TOTAL CAPITAL required for five years 404.000




3 Dimension of identified target groups
The proportion of the target market that is expected to be captured is about 25% in a 5 year time period. However the size of the market is growing rapidly, which is translated with larger sales potential worldwide.


4 Evaluation of financial Risks for R&D result
The financial risks related with the development are moderate. There is risk involved because the potential product is still in a development stage, meaning that a period of time (1-1,5 years) is needed for the actual product to reach the market and start making economic profits. However once the product has reached the market, there is both active and hidden demand for it, as well as large profit margins. The low production costs are also an important aspect that proves the profit potential of the new product.



 After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 1. European FundingDefine relevance of the product with the following potential funding sources and comment


2. National Funding
  • National Innovation Programs, for example National Strategic Reference Framework (ESPA) could be used for development and marketing costs
  • Business loans from Greek Banks 


3. Private funding
  • Private capital 




It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
 For the exploitation of the R&D result the most suitable solutions would be the following:-                a private investor to take on the whole project and occupy the R&D team in order to develop  and produce the final product

-                A joint further development agreement with an established firm of the relevant market

-                A spin off


Decision of evaluation

  • The R&D has a high potential of exploitation but extensive further development is necessary in order to become a complete new product.
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project